Menu Close

BIO-key takes $2.2 million in short-term debt financing for working capital

BIO-key has raised $2.2 million in funding through a promissory note, with plans to use the funds for general working capital.

The company has been expanding the reach of its biometric IAM solutions by signing up distributors, including most recently for the Southeast Asia region. It also signed up two counties in the U.S. as customers for its biometric access control platform PortalGuard.

The promissory note is issued with a six-month term at a 10 percent interest rate to AJB Capital Investments.

“As we look to opportunities next year, we elected to secure short-term funding to enhance our financial position,” comments CEO Michael DePasquale. “Today’s debt financing makes the most sense for our company and stakeholders in today’s market environment. We are confident in BIO-key’s global outlook in 2023 and our ability to service our obligations under the Note. We expect to enter the year with roughly $7M in annual recurring SaaS revenues from software contracts, a solid pipeline of customer opportunities, and hardware inventory that we look to convert to cash.”

BIO-key says the note was issued at a 9 percent original issue discount, and can be extended for an additional 6 months as a 12 percent rate. The investor also gets 700,000 shares of BIO-key’s common stock as payment of a commitment fee, and a five-year warrant to purchase another 200,000 at $3.00 each. If BIO-key has fully repaid the note within the six-month term, it will repurchase 350,000 shares initially issued for $1.00 in aggregate, according to the announcement.

The deal also includes a condition for converting the note into shares if BIO-key defaults. AJB’s total share acquisition from the deal is capped at 19.9 percent of BIO-key’s issued and outstanding shares. BIO-key has raised $2.2 million in funding through a promissory note, with plans to use the funds for general working capital.

The company has been expanding the reach of its biometric IAM solutions by signing up distributors, including most recently for the Southeast Asia region. It also signed up two counties in the U.S. as customers for its biometric access control platform PortalGuard.

The promissory note is issued with a six-month term at a 10 percent interest rate to AJB Capital Investments.

“As we look to opportunities next year, we elected to secure short-term funding to enhance our financial position,” comments CEO Michael DePasquale. “Today’s debt financing makes the most sense for our company and stakeholders in today’s market environment. We are confident in BIO-key’s global outlook in 2023 and our ability to service our obligations under the Note. We expect to enter the year with roughly $7M in annual recurring SaaS revenues from software contracts, a solid pipeline of customer opportunities, and hardware inventory that we look to convert to cash.”

BIO-key says the note was issued at a 9 percent original issue discount, and can be extended for an additional 6 months as a 12 percent rate. The investor also gets 700,000 shares of BIO-key’s common stock as payment of a commitment fee, and a five-year warrant to purchase another 200,000 at $3.00 each. If BIO-key has fully repaid the note within the six-month term, it will repurchase 350,000 shares initially issued for $1.00 in aggregate, according to the announcement.

The deal also includes a condition for converting the note into shares if BIO-key defaults. AJB’s total share acquisition from the deal is capped at 19.9 percent of BIO-key’s issued and outstanding shares.  Read More  Biometric Update 

Generated by Feedzy

Disclaimer

Innov8 is owned and operated by Rolling Rock Ventures. The information on this website is for general information purposes only. Any information obtained from this website should be reviewed with appropriate parties if there is any concern about the details reported herein. Innov8 is not responsible for its contents, accuracies, and any inaccuracies. Nothing on this site should be construed as professional advice for any individual or situation. This website includes information and content from external sites that is attributed accordingly and is not the intellectual property of Innov8. All feeds ("RSS Feed") and/or their contents contain material which is derived in whole or in part from material supplied by third parties and is protected by national and international copyright and trademark laws. The Site processes all information automatically using automated software without any human intervention or screening. Therefore, the Site is not responsible for any (part) of this content. The copyright of the feeds', including pictures and graphics, and its content belongs to its author or publisher.  Views and statements expressed in the content do not necessarily reflect those of Innov8 or its staff. Care and due diligence has been taken to maintain the accuracy of the information provided on this website. However, neither Innov8 nor the owners, attorneys, management, editorial team or any writers or employees are responsible for its content, errors or any consequences arising from use of the information provided on this website. The Site may modify, suspend, or discontinue any aspect of the RSS Feed at any time, including, without limitation, the availability of any Site content.  The User agrees that all RSS Feeds and news articles are for personal use only and that the User may not resell, lease, license, assign, redistribute or otherwise transfer any portion of the RSS Feed without attribution to the Site and to its originating author. The Site does not represent or warrant that every action taken with regard to your account and related activities in connection with the RSS Feed, including, without limitation, the Site Content, will be lawful in any particular jurisdiction. It is incumbent upon the user to know the laws that pertain to you in your jurisdiction and act lawfully at all times when using the RSS Feed, including, without limitation, the Site Content.  

Close Bitnami banner
Bitnami